Fundz

ReAlta Life Sciences, Inc. Appoints David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer

PRIVATEAug 22, 2024

Position

Chief Research Officer

Company

ReAlta Life Sciences

Paolo Martini
pmartini@realtals.com
NorfolkBiotechnologyHealthcareHealth Care

Description

ReAlta Life Sciences, Inc. announced the appointment of David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer. The company believes that the two distinguished biopharmaceutical veterans are the ideal leaders for these pivotal roles as it evolves into a late-stage development company with multiple clinical programs spanning three distinct therapeutic areas with significant unmet need.

Quick answer

ReAlta Life Sciences, Inc. Appoints David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer (August 22, 2024). ReAlta Life Sciences is based in Norfolk, Virginia, United States.

Who is the new Chief Research Officer at ReAlta Life Sciences?
ReAlta Life Sciences named Paolo Martini Chief Research Officer, announced August 22, 2024.
What did ReAlta Life Sciences announce on August 22, 2024?
ReAlta Life Sciences, Inc. announced the appointment of David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer. The company believes that the two distinguished biopharmaceutical veterans are the ideal leaders for these pivotal roles as it evolves into a late-stage development company with multiple clinical programs spanning three distinct therapeutic areas with...
What does ReAlta Life Sciences do?
ReAlta Life Sciences is a clinical-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute inflammatory and rare diseases.
Where is ReAlta Life Sciences based?
ReAlta Life Sciences is based in Norfolk, Virginia, United States.
Which similar companies made leadership changes around the same time?
Climb Bio, Inc. (August 26, 2024), Tenon Medical (August 27, 2024), Insightec (September 3, 2024) and CHARM Therapeutics (September 10, 2024) also announced leadership changes within 45 days of ReAlta Life Sciences.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at ReAlta Life Sciences, and when

A new leader at ReAlta Life Sciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day ReAlta Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ReAlta Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ReAlta Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ReAlta Life Sciences

Location

5665 LOWERY ROAD, SUITE 100

Norfolk, Virginia, United States

About

ReAlta Life Sciences is a clinical-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute inflammatory and rare diseases. ReAlta’s EPICC peptides are based on research into the human astrovirus, HAstV-1, which causes a non-inflammatory, self-limiting gastroenteritis unique among viruses by inhibiting components of the innate immune system. ReAlta’s therapeutic peptides leverage these virus-derived mechanisms to rebalance complement and inflammatory processes in the body. The company’s pipeline is led by RLS-0071, which has received IND clearance by the U.S. Food and Drug Administration (FDA) for the treatment of acute exacerbations of chronic obstructive pulmonary disease and acute graft-versus-host disease, and IND clearance, Orphan Drug Designation, and Fast Track Designation by the FDA, and Orphan Drug Designation by the European Medicines Agency, for the treatment of hypoxic-ischemic encephalopathy (HIE). The company launched in 2018, and is located in Norfolk, Virginia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ReAlta Life Sciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Neel
Likely contact at this company
••••••••@••••••••

See Neel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ReAlta Life Sciences's next move

Learn about Strategic plan

ReAlta Life Sciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.